Clinical Trial

Polidocanol 1% and Steroid in Keloids and Hypertrophic Scars

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 26, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
we will inject intralesional polidocanol 1% in keloids and hypertrophic scars to decrease vascularity and decrease size of lesion compared to intralesional steroid as standard treatment line
Trial Details
NCT Number NCT07606391
Lead Sponsor Sohag University
Conditions Keloid and Hypertrophic Scars
Enrollment 90 participants
Start Date 2026-08-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-26